Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileGhazaleh Sadri-Vakili, Ph.D.

TitleAssistant Professor of Neurology
InstitutionMassachusetts General Hospital
DepartmentNeurology
AddressMass General Hospital
Bldg 114, Room 2200
114 16th Street
Charlestown MA 02129
Phone617/724-1487
vCardDownload vCard (login for email)

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. McCarthy DM, Mueller KA, Cannon EN, Huizenga MN, Darnell SB, Bhide PG, Sadri-Vakili G. Prenatal Cocaine Exposure Alters BDNF-TrkB Signaling in the Embryonic and Adult Brain. Dev Neurosci. 2016; 38(5):365-374. PMID: 28132054.
    View in: PubMed
  2. McCarthy DM, Bell GA, Cannon EN, Mueller KA, Huizenga MN, Sadri-Vakili G, Fadool DA, Bhide PG. Reversal Learning Deficits Associated with Increased Frontal Cortical Brain-Derived Neurotrophic Factor Tyrosine Kinase B Signaling in a Prenatal Cocaine Exposure Mouse Model. Dev Neurosci. 2016; 38(5):354-364. PMID: 27951531.
    View in: PubMed
  3. Glajch KE, Ferraiuolo L, Mueller KA, Stopford MJ, Prabhkar V, Gravanis A, Shaw PJ, Sadri-Vakili G. MicroNeurotrophins Improve Survival in Motor Neuron-Astrocyte Co-Cultures but Do Not Improve Disease Phenotypes in a Mutant SOD1 Mouse Model of Amyotrophic Lateral Sclerosis. PLoS One. 2016; 11(10):e0164103. PMID: 27716798.
    View in: PubMed
  4. LaQuaglia MJ, Grijalva JL, Mueller KA, Perez-Atayde AR, Kim HB, Sadri-Vakili G, Vakili K. YAP Subcellular Localization and Hippo Pathway Transcriptome Analysis in Pediatric Hepatocellular Carcinoma. Sci Rep. 2016 Sep 08; 6:30238. PMID: 27605415; PMCID: PMC5015017.
  5. Batalha VL, Ferreira DG, Coelho JE, Valadas JS, Gomes R, Temido-Ferreira M, Shmidt T, Baqi Y, Buée L, Müller CE, Hamdane M, Outeiro TF, Bader M, Meijsing SH, Sadri-Vakili G, Blum D, Lopes LV. The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. Sci Rep. 2016 Aug 11; 6:31493. PMID: 27510168; PMCID: PMC4980603.
  6. Vodicka P, Mo S, Tousley A, Green KM, Sapp E, Iuliano M, Sadri-Vakili G, Shaffer SA, Aronin N, DiFiglia M, Kegel-Gleason KB. Mass Spectrometry Analysis of Wild-Type and Knock-in Q140/Q140 Huntington's Disease Mouse Brains Reveals Changes in Glycerophospholipids Including Alterations in Phosphatidic Acid and Lyso-Phosphatidic Acid. J Huntingtons Dis. 2015; 4(2):187-201. PMID: 26397899.
    View in: PubMed
  7. Glajch KE, Sadri-Vakili G. Epigenetic Mechanisms Involved in Huntington's Disease Pathogenesis. J Huntingtons Dis. 2015; 4(1):1-15. PMID: 25813218.
    View in: PubMed
  8. Satterlee JS, Basanta-Sanchez M, Blanco S, Li JB, Meyer K, Pollock J, Sadri-Vakili G, Rybak-Wolf A. Novel RNA modifications in the nervous system: form and function. J Neurosci. 2014 Nov 12; 34(46):15170-7. PMID: 25392485; PMCID: PMC4402329.
  9. Schmidt HD, McFarland KN, Darnell SB, Huizenga MN, Sangrey GR, Cha JH, Pierce RC, Sadri-Vakili G. ADAR2-dependent GluA2 editing regulates cocaine seeking. Mol Psychiatry. 2015 Nov; 20(11):1460-6. PMID: 25349168; PMCID: PMC4412769.
  10. Sadri-Vakili G. Cocaine triggers epigenetic alterations in the corticostriatal circuit. Brain Res. 2015 Dec 02; 1628(Pt A):50-9. PMID: 25301690; PMCID: PMC4387100 [Available on 12/02/16].
  11. Rasakham K, Schmidt HD, Kay K, Huizenga MN, Calcagno N, Pierce RC, Spires-Jones TL, Sadri-Vakili G. Synapse density and dendritic complexity are reduced in the prefrontal cortex following seven days of forced abstinence from cocaine self-administration. PLoS One. 2014; 9(7):e102524. PMID: 25072653; PMCID: PMC4114454.
  12. Grijalva JL, Huizenga M, Mueller K, Rodriguez S, Brazzo J, Camargo F, Sadri-Vakili G, Vakili K. Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration. Am J Physiol Gastrointest Liver Physiol. 2014 Jul 15; 307(2):G196-204. PMID: 24875096.
    View in: PubMed
  13. Licata SC, Shinday NM, Huizenga MN, Darnell SB, Sangrey GR, Rudolph U, Rowlett JK, Sadri-Vakili G. Alterations in brain-derived neurotrophic factor in the mouse hippocampus following acute but not repeated benzodiazepine treatment. PLoS One. 2013; 8(12):e84806. PMID: 24367698; PMCID: PMC3868703.
  14. McFarland KN, Huizenga MN, Darnell SB, Sangrey GR, Berezovska O, Cha JH, Outeiro TF, Sadri-Vakili G. MeCP2: a novel Huntingtin interactor. Hum Mol Genet. 2014 Feb 15; 23(4):1036-44. PMID: 24105466; PMCID: PMC3900110.
  15. Vassoler FM, Sadri-Vakili G. Mechanisms of transgenerational inheritance of addictive-like behaviors. Neuroscience. 2014 Apr 04; 264:198-206. PMID: 23920159; PMCID: PMC3872494.
  16. Vashishtha M, Ng CW, Yildirim F, Gipson TA, Kratter IH, Bodai L, Song W, Lau A, Labadorf A, Vogel-Ciernia A, Troncosco J, Ross CA, Bates GP, Krainc D, Sadri-Vakili G, Finkbeiner S, Marsh JL, Housman DE, Fraenkel E, Thompson LM. Targeting H3K4 trimethylation in Huntington disease. Proc Natl Acad Sci U S A. 2013 Aug 06; 110(32):E3027-36. PMID: 23872847; PMCID: PMC3740882.
  17. Schmidt HD, McGinty JF, West AE, Sadri-Vakili G. Epigenetics and psychostimulant addiction. Cold Spring Harb Perspect Med. 2013 Mar 01; 3(3):a012047. PMID: 23359110; PMCID: PMC3579203.
  18. McFarland KN, Das S, Sun TT, Leyfer D, Kim MO, Xia E, Sangrey GR, Kuhn A, Luthi-Carter R, Clark TW, Sadri-Vakili G, Cha JH. Genome-wide increase in histone H2A ubiquitylation in a mouse model of Huntington's disease. J Huntingtons Dis. 2013; 2(3):263-77. PMID: 25062675.
    View in: PubMed
  19. Vassoler FM, White SL, Schmidt HD, Sadri-Vakili G, Pierce RC. Epigenetic inheritance of a cocaine-resistance phenotype. Nat Neurosci. 2013 Jan; 16(1):42-7. PMID: 23242310; PMCID: PMC3531046.
  20. McFarland KN, Das S, Sun TT, Leyfer D, Xia E, Sangrey GR, Kuhn A, Luthi-Carter R, Clark TW, Sadri-Vakili G, Cha JH. Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease. PLoS One. 2012; 7(7):e41423. PMID: 22848491; PMCID: PMC3407195.
  21. Jia H, Pallos J, Jacques V, Lau A, Tang B, Cooper A, Syed A, Purcell J, Chen Y, Sharma S, Sangrey GR, Darnell SB, Plasterer H, Sadri-Vakili G, Gottesfeld JM, Thompson LM, Rusche JR, Marsh JL, Thomas EA. Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease. Neurobiol Dis. 2012 May; 46(2):351-61. PMID: 22590724; PMCID: PMC3528106.
  22. Ritch JJ, Valencia A, Alexander J, Sapp E, Gatune L, Sangrey GR, Sinha S, Scherber CM, Zeitlin S, Sadri-Vakili G, Irimia D, Difiglia M, Kegel KB. Multiple phenotypes in Huntington disease mouse neural stem cells. Mol Cell Neurosci. 2012 May; 50(1):70-81. PMID: 22508027; PMCID: PMC3383872.
  23. Schmidt HD, Sangrey GR, Darnell SB, Schassburger RL, Cha JH, Pierce RC, Sadri-Vakili G. Increased brain-derived neurotrophic factor (BDNF) expression in the ventral tegmental area during cocaine abstinence is associated with increased histone acetylation at BDNF exon I-containing promoters. J Neurochem. 2012 Jan; 120(2):202-9. PMID: 22043863; PMCID: PMC3243782.
  24. McCarthy DM, Zhang X, Darnell SB, Sangrey GR, Yanagawa Y, Sadri-Vakili G, Bhide PG. Cocaine alters BDNF expression and neuronal migration in the embryonic mouse forebrain. J Neurosci. 2011 Sep 21; 31(38):13400-11. PMID: 21940433; PMCID: PMC3182852.
  25. Sadri-Vakili G, Kumaresan V, Schmidt HD, Famous KR, Chawla P, Vassoler FM, Overland RP, Xia E, Bass CE, Terwilliger EF, Pierce RC, Cha JH. Cocaine-induced chromatin remodeling increases brain-derived neurotrophic factor transcription in the rat medial prefrontal cortex, which alters the reinforcing efficacy of cocaine. J Neurosci. 2010 Sep 01; 30(35):11735-44. PMID: 20810894; PMCID: PMC2943400.
  26. Benn CL, Luthi-Carter R, Kuhn A, Sadri-Vakili G, Blankson KL, Dalai SC, Goldstein DR, Spires TL, Pritchard J, Olson JM, van Dellen A, Hannan AJ, Cha JH. Environmental enrichment reduces neuronal intranuclear inclusion load but has no effect on messenger RNA expression in a mouse model of Huntington disease. J Neuropathol Exp Neurol. 2010 Aug; 69(8):817-27. PMID: 20613636.
    View in: PubMed
  27. Famous KR, Kumaresan V, Sadri-Vakili G, Schmidt HD, Mierke DF, Cha JH, Pierce RC. Phosphorylation-dependent trafficking of GluR2-containing AMPA receptors in the nucleus accumbens plays a critical role in the reinstatement of cocaine seeking. J Neurosci. 2008 Oct 22; 28(43):11061-70. PMID: 18945913; PMCID: PMC2601563.
  28. Benn CL, Sun T, Sadri-Vakili G, McFarland KN, DiRocco DP, Yohrling GJ, Clark TW, Bouzou B, Cha JH. Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner. J Neurosci. 2008 Oct 15; 28(42):10720-33. PMID: 18923047; PMCID: PMC2586288.
  29. Sadri-Vakili G, Janis GC, Pierce RC, Gibbs TT, Farb DH. Nanomolar concentrations of pregnenolone sulfate enhance striatal dopamine overflow in vivo. J Pharmacol Exp Ther. 2008 Dec; 327(3):840-5. PMID: 18772319; PMCID: PMC2864155.
  30. Broom WJ, Greenway M, Sadri-Vakili G, Russ C, Auwarter KE, Glajch KE, Dupre N, Swingler RJ, Purcell S, Hayward C, Sapp PC, McKenna-Yasek D, Valdmanis PN, Bouchard JP, Meininger V, Hosler BA, Glass JD, Polack M, Rouleau GA, Cha JH, Hardiman O, Brown RH. 50bp deletion in the promoter for superoxide dismutase 1 (SOD1) reduces SOD1 expression in vitro and may correlate with increased age of onset of sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008 Aug; 9(4):229-37. PMID: 18608091.
    View in: PubMed
  31. Kim MO, Chawla P, Overland RP, Xia E, Sadri-Vakili G, Cha JH. Altered histone monoubiquitylation mediated by mutant huntingtin induces transcriptional dysregulation. J Neurosci. 2008 Apr 09; 28(15):3947-57. PMID: 18400894; PMCID: PMC3844822.
  32. Anderson SM, Famous KR, Sadri-Vakili G, Kumaresan V, Schmidt HD, Bass CE, Terwilliger EF, Cha JH, Pierce RC. CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking. Nat Neurosci. 2008 Mar; 11(3):344-53. PMID: 18278040.
    View in: PubMed
  33. Kim, M., Chawla, P., Overland, R.P., E. Xia, Sadri-Vakili, G., Cha, J.-H.J. Mutant Huntingtin-mediated histone monoubiquitylation induces transcriptional dysregulation in Huntington’s disease. Journal of Neuroscience. 2008; in press.
  34. Broom, W.J., Greenway, M., Sadri-Vakili, G., Russ, C., Auwrter, K.E., Glajch, K.E., Swingler, R.J., Purcell, S., Sapp, P.C., McKenna-Yasek, D., Hosler, B.A., Horvitz, H.R., Glass, J.D., Cha, J.H.J., Hardiman, O., Brown Jr., R.H. 50bp deletion in the promoter for SOD1 promoter reduces SOD1 expression in vitro and correlates with population-specific increased age of onset in sporadic ALS. Amyotrophic Lateral Sclerosis. 2008; in press.
  35. Sadri-Vakili, G. Histones Associated with Downregulated Genes are Hypo-acetylated in Huntington’s Disease Models. 2008.
  36. Benn, C.L. and Sadri-Vakili, G. Misfolded huntingtin protein and implications for transcriptional dysregulation. Protein Misfolding in Biology and Disease. 2008; in press.
  37. Sadri-Vakili G, Bouzou B, Benn CL, Kim MO, Chawla P, Overland RP, Glajch KE, Xia E, Qiu Z, Hersch SM, Clark TW, Yohrling GJ, Cha JH. Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models. Hum Mol Genet. 2007 Jun 01; 16(11):1293-306. PMID: 17409194.
    View in: PubMed
  38. Sadri-Vakili, G., Bouzou, B., Benn, C.L., Kim, M., Chawla, P., Overland, R.P., Glajch, K.E., Xia, E., Qui, Z., Hersch, S.M., Clark, T.W., Yohrling, G.J., Cha, J.-H.J. Histones Associated with Downregulated Genes are Hypo-acetylated in Huntington’s Disease Models. Gordon Conference on CAG triplet repeat disorders. 2007.
  39. Sadri-Vakili, G. Epigenetics of cocaine addiction. 40th Winter Conference on Brain Research. 2007.
  40. Cha, J.-H.J., Bouzou, B., Benn, C.L., Kim, M., Chawla, P., Overland, R.P., Glajch, K.E., Xia, E., Qui, Z., Hersch, S.M., Clark, T.W., Yohrling, G.J., Sadri-Vakili, G. . Histones Associated with Downregulated Genes are Hypo-acetylated in Huntington’s Disease Models. Society for Neuroscience 37th Annual Meeting. 2007.
  41. Famous, K.R., Sadri-Vakili, G., Kumaresan, V., Schmidt, H.D., Cha, J.-H.J., Pierce, R.C. Increased transcription of CaM-KII in the rat medial prefrontal cortex promotes the reinstatement of cocaine-seeking behavior. Society for Neuroscience 37th Annual Meeting. 2007.
  42. Kim, M., Chawla, P., Ovelnand, R.P., Sadri-Vakili, G., Cha, J.-H.J. . Mutant huntingtin mediated histone monoubiquitylation induces transcriptional dysregulation in Huntington’s disease. Society for Neuroscience 37th Annual Meeting. 2007.
  43. Sadri-Vakili, G., Kumaresan, V., Famous, K.R., Overland, R.P., Xia, E., Schmidt, H.D., Pierce, R.C., Cha, J.-H.J. . Epigenetic regulation of cocaine-induced increases in Brain-derived Neurotrophic Factor transcript in the medial Prefrontal Cortex of the rat. Society for Neurosceince 37th Annual Meeting. 2007.
  44. Benn, C.L., Sun, T., Sadri-Vakili, G., Overland, R.P., Vasan, A., DiRocco, D.P., Yohrling, G.J., Clark, T.W., Bouzou, B., Cha, J.-H.J. . Huntingtin modulates transcription, occupies gene promoters in vivo and binds directly to DNA in a polyglutamine dependent manner. Society for Neuroscience 37th Annual Meeting. 2007.
  45. Sadri-Vakili G, Cha JH. Histone deacetylase inhibitors: a novel therapeutic approach to Huntington's disease (complex mechanism of neuronal death). Curr Alzheimer Res. 2006 Sep; 3(4):403-8. PMID: 17017871.
    View in: PubMed
  46. Sadri-Vakili, G., Chawla, P., Glajch, K.E., Overland, R.P., Cha, J.-H.J. . Histones associated with downregulated genes are hypo-acetylated in in vitro models of Huntington’s disease. HD 2006: Changes, Advances, and good news (CAG)n. 2006.
  47. Sadri-Vakili G, Menon AS, Farrell LA, Keller-McGandy CE, Cantuti-Castelvetri I, Standaert DG, Augood SJ, Yohrling GJ, Cha JH. Huntingtin inclusions do not down-regulate specific genes in the R6/2 Huntington's disease mouse. Eur J Neurosci. 2006 Jun; 23(12):3171-5. PMID: 16820007.
    View in: PubMed
  48. Sadri-Vakili G, Cha JH. Mechanisms of disease: Histone modifications in Huntington's disease. Nat Clin Pract Neurol. 2006 Jun; 2(6):330-8. PMID: 16932577.
    View in: PubMed
  49. Chen-Plotkin AS, Sadri-Vakili G, Yohrling GJ, Braveman MW, Benn CL, Glajch KE, DiRocco DP, Farrell LA, Krainc D, Gines S, MacDonald ME, Cha JH. Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease. Neurobiol Dis. 2006 May; 22(2):233-41. PMID: 16442295.
    View in: PubMed
  50. Cha, J.-H.J., Benn, C.L., Chawla, P., Glajch, K.E., Kim, M., Overland, R.P., Sadri-Vakili, G., Sun, T. . Mechanisms of transcriptional dysregulation in Huntington’s disease. Society for Neurosceince 35th Annual Meeting. 2005.
  51. Sadri-Vakili, G., Chawla, P., Glajch, K.E., Overland, R.P., Cha, J.-H.J. . Histone modifications in Huntington’s disease. Society for Neurosceince 35th Annual Meeting,. 2005.
  52. Sadri-Vakili, G., Chawla, P., Glajch, K.E., Overland, R.P., Cha, J.-H.J. . Histone modifications in Huntington’s disease. American Neurological Association 130th Annual Meeting, plenary talk. 2005.
  53. Sadri-Vakili, G., Chawla, P., Glajch, K.E., Overland, R.P., Cha, J.-H.J. Histone modifications in Huntington’s disease. Gordon Research Conference, CAG triplet repeat disorders. 2005.
  54. Sadri-Vakili, G., Farrell, L.A., Penney E.B., Cha, J.-H.J. . Analysis of histone modifications in Huntington’s disease. Society for Neurosceince 34th Annual Meeting,. 2004.
  55. Norflus, F., Chopra, V., Singh, B., Chopra, R., Swindell, K., Fox, J., Sadri-Vakili, G., Farrell, L.A., Cha, J.-H.J., Ryu, H., Ferrante, R.J., Hersch, S.M. . 5-AZA-2’-Deoxycytidine is neuroprotective in N171-82Q and R6/2 Huntington’s disease transgenic mice. HDSA coalition for the cure 8th Annual Meeting,. 2004.
  56. Sadri-Vakili, G., Farrell, L.A., Penney E.B., Cha, J.-H.J. Analysis of histone modifications in Huntington’s disease. HDSA coalition for the cure 8th Annual Meeting,. 2004.
  57. Sadri-Vakili, G., Farrell, L.A., Penney E.B., Cha, J.-H.J. . Analysis of histone modifications in Huntington’s disease. HDF 2004: Changes, Advances, and good news (CAG)n. 2004.
  58. Farb, David H., Sadri-Vakili, Ghazaleh; Pierce, Robert Christopher; Johnson, David W; Gibbs, Terrell T. Neuroactive steroid derivatives and method of use. 2004.
  59. Sadri-Vakili, G., Penney, E.B., Farrell, L.A., Braveman, M.W., Cha, J.-H.J. . Chromatin Immunoprecipitation analysis of histone modificaitons in Huntington’s disease. Society for Neuroscience 33rd Annual Meeting,. 2003.
  60. Sadri-Vakili G, Johnson DW, Janis GC, Gibbs TT, Pierce RC, Farb DH. Inhibition of NMDA-induced striatal dopamine release and behavioral activation by the neuroactive steroid 3alpha-hydroxy-5beta-pregnan-20-one hemisuccinate. J Neurochem. 2003 Jul; 86(1):92-101. PMID: 12807429.
    View in: PubMed
  61. Ghazaleh Sadri-Vakili. Neurosteroids modulate ionotropic glutamate receptor-induced dopamine release and locomotor acticity in the rat. 2003.
  62. Sadri-Vakili, G., Janis, G.C., Gibbs, T.T., Pierce, R.C., and Farb, D.H. . Pregnenolone sulfate increases dopamine release in the rat striatum. Society for Neuroscience 32th Annual Meeting,. 2002.
  63. Sadri-Vakili, G., Janis, G.C., Johnson, D.W., Pierce, R.C., and Farb, D.H. . Inhibition of NMDA-induced striatal dopamine release and behavioral activation by the neuroactive steroid 3?-Hydroxy-5?-Pregnan-20-One Hemisuccinate. 30th New England Pharmacologist Meeting,. 2001.
  64. Sadri, G., Johnson, D.W., Janis, G.C., Gibbs, T.T., Pierce, R.C., and Farb, D.H. . Inhibition of dopamine release through modulation of excitatory amino acid receptors by a neuroactive steroid. Society for Neuroscience 30th Annual Meeting,. 2000.
  65. Sadri, G., Johnson, D.W., Janis, G.C., Pierce, R.C., and Farb, D.H. Neurosteroids modulate excitatory amino acid receptor-mediated dopamine release in the striatum of awake rats. American Society for Pharmacology and Experimental Therapeutics Meeting,. 2000.
  66. Sadri, G., Johnson, D.W., Janis, G.C., Pierce, R.C., and Farb, D.H. Neurosteroids modulate excitatory amino acid receptor-mediated dopamine release in the striatum of awake rats. 6th Annual Russek Student Achievement Day. 2000.
  67. Sadri, G., Johnson, D.W., Janis, G.C., Pierce, R.C., and Farb, D.H. . Neurosteroids modulate excitatory amino acid receptor-mediated dopamine release in the striatum of awake rats. New England Pharmacologists 29th Annual Meeting,. 2000.
  68. Sadri, G., Janis, G.C., Pierce, R.C., Johnson, D.W., and Farb, D.H. Pregnanolone hemisuccinate negatively modulates ionotropic glutamate receptors in the rat striatum as measured by in vivo microdialysis. 5th Annual Russek Student Achievement Day. 1999.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Sadri-Vakili's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_